Abstract
Published in cooperation with McEvoy and Farmer. Not part of any Kalorama
Information subscription package. Not available on Profound aggregator due to
license restrictions. The Chinese market represents a significant opportunity
for IVD diagnostic companies. But actionable information about this emerging
market is often difficult to get. Only with an exhaustive, on-the-ground
research team can a company truly understand the chinese market. Now, a
resource is available that can make on-the-ground research available to all
companies at a fraction of the cost. Published jointly with trusted Asian IVD
market experts McEvoy and Farmer, this Kalorama report is a complete survey of
the IVD market in China today. Market size for major categories of the IVD
market, products on the market, important Chinese market trends and intense
company profiles are part of this exhaustive study.
There is not a year when McEvoy and Farmer have completed their exhaustive
research on the Chinese IVD market when China has now shown growth. This most
recent version, the result of detailed on-the-ground research, is no exception.
This country of 1.3 billion people is now America' s sixth largest export
market, and China' s economy, which has been growing at an average rate of 8%
over the last 20 years, grew over 9% last year.
Combined with this impressive overall growth, a number of recent events and
trends in the Chinese healthcare environment are making China an increasingly
attractive market opportunity for in vitro diagnostics companies. China' s
accession to the World Trade Organization (WTO) has made doing business in
China much easier for diagnostic companies by reducing tariffs and opening the
door for foreign firms to control their own distribution. The increasing
numbers of private laboratories and expanded reference laboratories are
expanding the market for tests of all kinds.
Although there are a number of challenges for diagnostic manufacturers to
understand and overcome, the market for clinical diagnostics in China (both
reagents and instruments) remains one of the most promising emerging markets
in the world.
The report covers seven market segments:
- Coagulation
- Critical Care Chemistry
- Hematology
- Immunochemistry
- Molecular Testing
- Routine Chemistry
- Urine Chemistry
For each segment, the report provides key market data such as market size,
number of labs and their workload, level of automation, and market share for
both instrument and reagent competitors, foreign and domestic.
Perhaps the most valuable part of the report, however, is the extensive
listing of market participants. The report profiles:
- 40 international manufacturers active in China, their local contacts and
distributors, and discussing their position in the Chinese IVD market
- Over 100 domestic manufacturers, their contact information, specialties,
and products
- 43 local distributors, their contact information and companies represented
(and a distributors cross-reference allows the reader to easily look up who is
distributing for whom)
View Cart
